**Core Concept**
Retroperitoneal fibrosis (RPF) is a rare condition characterized by the proliferation of fibrous tissue in the retroperitoneum, leading to the entrapment and obstruction of surrounding structures. The diagnosis and management of RPF require a thorough understanding of its pathophysiology, clinical presentation, and potential complications.

**Why the Correct Answer is Right**
The management of RPF involves a combination of imaging studies, including CT scans and MRI, to assess the extent of fibrosis and potential complications. The primary treatment for RPF is surgical intervention, specifically a retroperitoneal lymph node dissection (RPLND) or a debulking procedure, to relieve compression on surrounding structures. Medical management with corticosteroids or immunosuppressive agents may be used as an adjunctive therapy to reduce inflammation and fibrosis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because RPF is not typically managed with antibiotics, as it is not an infectious process. The use of antibiotics would not address the underlying fibrosis and potential complications.

**Option B:** This option is incorrect because the primary treatment for RPF is surgical intervention, not medical management alone. While corticosteroids or immunosuppressive agents may be used as an adjunctive therapy, they are not sufficient to manage the condition.

**Option C:** This option is incorrect because RPF is not typically associated with a high risk of malignancy. While some cases of RPF may be associated with underlying malignancies, such as lymphoma or carcinoid tumors, this is not a universal characteristic of the condition.

**Clinical Pearl / High-Yield Fact**
It is essential to note that RPF can be a challenging diagnosis, and a high index of suspicion is required to identify the condition. A thorough review of imaging studies and a detailed clinical history are crucial in making an accurate diagnosis and developing an effective treatment plan.

**Correct Answer: C. RPF is not typically associated with a high risk of malignancy.

✓ Correct Answer: D. The prognosis for nonmalignant retroperitoneal fibrosis is grim with progression of disease until death occurring in most patients